|
Section Two Drug Index Regional Medical Center at Memphis Drug Formulary |
|
||||||||
|
|
|
||||||||
|
Legend: |
|
||||||||
|
Sizes, strengths and dosage form information for drugs will be found under the generic name of drug. Frequently encountered trade names of a drug will be found in parentheses behind the generic name. |
|
||||||||
|
ALL CAPITAL LETTERS = Generic name of drug. |
|
||||||||
|
C = Controlled Drug which requires DEA number; full name and address of prescriber; and full name and address of patient. |
|
||||||||
|
® = Registered tradename of drug. Frequently encountered tradenames of a generic drug may be cross- referenced to the drug's generic name. |
|
||||||||
|
|
|
||||||||
|
Example: C-ACETAMINOPHEN WITH CODEINE (Tylenol #3®) |
|
||||||||
|
|
|
||||||||
|
|
|
||||||||
|
A AND D OINTMENT (inpatient only) |
|
||||||||
|
|
Ointment, topical |
|
|||||||
|
|
|
|
|||||||
|
ABCIXIMAB (ReoPro®) |
|
||||||||
|
|
Injection: 2 milligrams/ milliliter (5 milliliters vial) |
|
|||||||
|
|
|
|
|||||||
|
ACCUZYME®: see PAPAIN-UREA |
|
||||||||
|
|
|
|
|||||||
|
ACETAMINOPHEN (Tylenol®) |
|
||||||||
|
|
Liquid, oral: 325 milligrams/12.5 milliliters, 650 milligrams/25 milliliters, 160 milligrams |
|
|||||||
|
|
Drops, oral: 60 milligrams/0.6 milliliter; 15 milliliters |
|
|||||||
|
|
Tablet: 325 milligrams |
|
|||||||
|
|
Suppository: 120 milligrams, 300 milligrams, 600 milligrams |
|
|||||||
|
|
|
|
|||||||
|
C-ACETAMINOPHEN WITH CODEINE (such as Tylenol #3®) |
|
||||||||
|
|
Liquid: 120 milligrams with Codeine 12 milligrams/5 milliliters |
|
|||||||
|
|
Tablet: 300 milligrams with Codeine 30 milligrams |
|
|||||||
|
|
|
|
|||||||
|
C II-ACETAMINOPHEN WITH OXYCODONE (5 milligrams) |
|
||||||||
|
|
Tablet: 325 milligrams with 5 milligrams oxycodone |
|
|||||||
|
|
Orders must specify strength |
|
|||||||
|
|
|
|
|||||||
|
ACETAZOLAMIDE |
|
||||||||
|
|
Injection: 500 milligram vial |
|
|||||||
|
|
Tablet: 250 milligrams |
|
|||||||
|
|
Capsule, prolonged action: 500 milligrams |
|
|||||||
|
|
|
|
|||||||
|
ACETIC ACID SOLUTION |
|
||||||||
|
|
Irrigating solution: 0.25%; 1000 milliliters |
|
|||||||
|
|
|
|
|||||||
|
ACETONE |
|
||||||||
|
|
Liquid: 16 ounce bottle |
|
|||||||
|
|
|
|
|||||||
|
ACETOHEXAMIDE (Dymelor®) |
|
||||||||
|
|
Tablet: 250 milligrams, 500 milligrams |
|
|||||||
|
|
|
|
|||||||
|
ACETYLCYSTEINE (Mucomyst®) |
|
||||||||
|
|
Solution: 20%; 4 milliliters, 30 milliliters vial |
|
|||||||
|
|
|
||||||||
|
Actonel®: see RISEDRONATE |
|
||||||||
|
|
|
||||||||
|
Actos®: see PIOGLITAZONE |
|
||||||||
|
|
|
||||||||
|
ACYCLOVIR (Zovirax®) |
|
||||||||
|
|
Ointment: 5%; 15 gram tube |
|
|||||||
|
|
Injection: 500 milligrams/10 milliliters vial |
|
|||||||
|
|
Capsule: 200 milligrams |
|
|||||||
|
|
|
|
|||||||
|
ADENOSINE (Adenocard®) |
|
||||||||
|
|
Injection: 6 milligrams/2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
AGGRENOX (see aspirin/ extended-release dipyridamole) |
|
||||||||
|
|
|
||||||||
|
ALBUMIN NORMAL HUMAN SERUM |
|
||||||||
|
|
Injection: 5%, 12.5 grams albumin in 250 milliliters |
|
|||||||
|
|
Injection: 5%, 25 grams albumin in 500 milliliters |
|
|||||||
|
|
Injection: 25%, 12.5 grams albumin in 50 milliliters |
|
|||||||
|
|
Injection: 25%, 25 grams albumin in 100 milliliters |
|
|||||||
|
|
|
|
|||||||
|
ALBUTEROL SULFATE |
|
||||||||
|
|
Tablet: 2 milligrams |
|
|||||||
|
|
Oral Solution: 2 milligrams/5 milliliters |
|
|||||||
|
|
Inhalation: 0.5% Solution 20 milliliters, 3 milliliters |
|
|||||||
|
|
Inhaler: Metered dose inhaler |
|
|||||||
|
|
Continuous nebulization limited to patients in ICU's only. |
|
|||||||
|
|
|
|
|||||||
|
ALCOHOL (Ethanol, Ethyl Alcohol) |
|
||||||||
|
|
Bulk: 95% (190 Proof and 200 Proof) |
|
|||||||
|
|
Intravenous Injection: 5% in Dextrose 5% (D5W) 1000 milliliters |
|
|||||||
|
|
|
|
|||||||
|
ALCOHOL, DEHYDRATED (Absolute Alcohol) |
|
||||||||
|
|
Injection: 100% (200 Proof); 1 milliliter |
|
|||||||
|
|
|
|
|||||||
|
Allbee with C ®: see VITAMIN B COMPLEX WITH VITAMIN C |
|
||||||||
|
|
|
|
|||||||
|
ALLOPURINOL |
|
||||||||
|
|
Tablet: 100 milligrams, 300 milligrams |
|
|||||||
|
|
|
|
|||||||
|
ALOE VERA SPRAY |
|
||||||||
|
|
Topical Spray: 95% |
|
|||||||
|
|
Restricted to Burn Center only. |
|
|||||||
|
|
|
|
|||||||
|
ALOE VERA GEL |
|
||||||||
|
|
Topical gel: 95% |
|
|||||||
|
|
Restricted to Burn Center only. |
|
|||||||
|
|
|
|
|||||||
|
ALOE VERA GEL WITH LIDOCAINE |
|
||||||||
|
|
Topical Gel: 95% |
|
|||||||
|
|
Restricted to Burn Center only. |
|
|||||||
|
|
|
|
|||||||
|
Alphagan P®: see BRIMONIDINE |
|
||||||||
|
|
|
|
|||||||
|
ALPHA-INTERFERON |
|
||||||||
|
|
Injection: 3 million units, 5 million units, 10 million units, 25 million units |
|
|||||||
|
|
|
|
|||||||
|
C-ALPRAZOLAM (Xanax®) |
|
||||||||
|
|
Tablet: 1 milligrams |
|
|||||||
|
|
Restricted to Psychiatry consult and patients on alprazolam prior to admission. Use limited to inpatients only. |
|
|||||||
|
|
|
|
|||||||
|
ALPROSTADIL (Prostin VR Pediatric® Solution) |
|
||||||||
|
|
Injection: 500 micrograms/ milliliter; 1 milliliter |
|
|||||||
|
|
|
|
|||||||
|
ALTEPLASE (Activase®) (also known as TPA or Tissue Plasminogen Activator) |
|
||||||||
|
|
Injection: 50 milligram vials |
|
|||||||
|
|
|
|
|||||||
|
ALUMINUM ACETATE SOLUTION (Burrow's Solution) (inpatient only) |
|
||||||||
|
|
Tablet, effervescent: Aluminum sulfate and Calcium acetate (Domeboro®) |
|
|||||||
|
|
One tablet per pint of water yields a 1:20 solution |
|
|||||||
|
|
|
|
|||||||
|
ALUMINUM HYDROXIDE GEL |
|
||||||||
|
|
Tablet: 300 milligrams (such as Amphogel®) |
|
|||||||
|
|
Suspension: 180 milliliters bottle |
|
|||||||
|
|
|
|
|||||||
|
ALUMINUM HYDROXIDE GEL WITH MAGENSIUM HYDROXIDE AND SIMETHICONE (Maalox Plus X-Strength®) |
|
||||||||
|
|
Suspension: Aluminum Hydroxide Gel, 500 milligrams; |
|
|||||||
|
|
Magnesium Hydroxide Gel, 450 milligrams; |
|
|||||||
|
|
Simethicone, 40 milligrams per 5 milliliters; 6oz bottle |
|
|||||||
|
|
|
|
|||||||
|
AMANTADINE (Symmetrel®) |
|
||||||||
|
|
Capsule: 100 milligrams |
|
|||||||
|
|
|
|
|||||||
|
Ambien®: see ZOLPIDEM |
|
||||||||
|
|
|
|
|||||||
|
AMCINONIDE (Cyclocort®) (inpatient only) |
|
||||||||
|
|
Cream: 0.1%; 15gram, 60 gram |
|
|||||||
|
|
Ointment: 0.1%; 15 gram |
|
|||||||
|
|
|
|
|||||||
|
AMIKACIN SULFATE |
|
||||||||
|
|
Injection: 100 milligrams/2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
AMINOCAPROIC ACID (Amicar®) |
|
||||||||
|
|
Tablet: 500 milligrams |
|
|||||||
|
|
Liquid: 250 milligrams/ milliliter; 16oz bottle |
|
|||||||
|
|
Injection: 250 milligrams/ milliliter; 20 milliliters vial |
|
|||||||
|
|
|
|
|||||||
|
AMINOPHYLLINE |
|
||||||||
|
|
Liquid, oral: 105 milligrams/5 milliliters |
|
|||||||
|
|
(Each 5 milliliters equivalent to 90 milligrams theophylline) |
|
|||||||
|
|
Injection, intravenous: 250 milligrams; 10 milliliters |
|
|||||||
|
|
Injection, intravenous: 500 milligrams; 20 milliliters |
|
|||||||
|
|
Intravenous Injection: 500 milligrams in Dextrose 5% (D5W) 500 milliliters |
|
|||||||
|
|
|
|
|||||||
|
AMIODARONE |
|
||||||||
|
|
Tablet: 200 milligrams |
|
|||||||
|
|
|
|
|||||||
|
AMLODIPINE (Norvasc®) |
|
||||||||
|
|
Tablet:
5 milligrams, 10 milligrams
|
|
|||||||
|
AMITRIPTYLINE HYDROCHLORIDE |
|
||||||||
|
|
Tablet: 10 milligrams, 25 milligrams, 50 milligrams, 100 milligrams, 150 milligrams |
|
|||||||
|
|
Injection: 10 milligrams/ milliliter; 10 milliliters |
|
|||||||
|
AMMONIA, AROMATIC SPIRITS |
|
||||||||
|
|
Nasal Inhalant: 0.4 milliliter vaporole |
|
|||||||
|
|
|
|
|||||||
|
AMMONIUM CHLORIDE |
|
||||||||
|
|
Injection: 100 milliequivalents (5milliequivalents/ milliliter); 20 milliliters |
|
|||||||
|
|
|
|
|||||||
|
AMMONIUM LACTATE (Lac-Hydrin®) (inpatient only) |
|
||||||||
|
|
Lotion: 12%; 5oz |
|
|||||||
|
|
|
|
|||||||
|
CII-AMOBARBITAL SODIUM (Amytal®) |
|
||||||||
|
|
Injection: 500 milligrams |
|
|||||||
|
|
|
|
|||||||
|
AMOXICILLIN |
|
||||||||
|
|
Capsule: 250 milligrams, 500 milligrams |
|
|||||||
|
|
Powder for oral suspension: 125 milligrams/5 milliliters; 150 milliliters |
|
|||||||
|
|
250 milligrams/5 milliliters; 100 milliliters |
|
|||||||
|
|
250 milligrams/5 milliliters; 150 milliliters |
|
|||||||
|
|
|
|
|||||||
|
AMOXICILLIN – CLAVULANIC ACID (Augmentin®) |
|
||||||||
|
|
Tablet: 250 milligrams, 500 milligrams, 875 milligrams |
|
|||||||
|
|
Oral Suspension: 125 milligrams/5 milliliters; 250 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
AMPHOTERICIN-B |
|
||||||||
|
|
Injection: 50 milligram vial |
|
|||||||
|
|
|
|
|||||||
|
AMPHOTERICIN-B LIPID COMPLEX |
|
||||||||
|
|
Injection: 100 milligram vial |
|
|||||||
|
|
|
|
|||||||
|
AMPICILLIN |
|
||||||||
|
|
Capsule: 250 milligrams, 500 milligrams |
|
|||||||
|
|
Powder for oral suspension: 250 milligrams/5 milliliters; 100 milliliters, 200 milliliters |
|
|||||||
|
|
Injection: 250 milligrams, 500 milligrams, 1 gram, 2 grams vials, 10 Gram vials |
|
|||||||
|
|
|
|
|||||||
|
AMPICILLIN - SULBACTAM (Unasyn®) |
|
||||||||
|
|
Injection: 1.5 & 3 gram (contain 2 grams ampicillin plus 1 gram sulbactam) |
|
|||||||
|
|
For cost effective therapy in non-life threatening infections, consider 1.5 grams IV every 6 hours. Dosage must be reduced in renal insufficiency. |
|
|||||||
|
|
|
|
|||||||
|
AMYL NITRATE |
|
||||||||
|
|
Nasal Inhalant: 0.3 milliliter in fragile glass ampule in cloth |
|
|||||||
|
|
|
|
|||||||
|
ANTACIDS (2 only, determined by annual bids) |
|
||||||||
|
|
see: ALUMINUM HYDROXIDE (Alternagel®) or |
|
|||||||
|
|
ALUMINUM HYDROXIDE GEL WITH MAGNESIUM HYDROXIDE |
|
|||||||
|
|
AND SIMETHICONE (Maalox Plus X-Strength®) |
|
|||||||
|
|
|
|
|||||||
|
ANTHRALIN (Lasan®) (inpatient only) |
|
||||||||
|
|
Ointment: 0.4%; 4oz bottle |
|
|||||||
|
|
|
|
|||||||
|
ANTIHEMOPHILLIC FACTOR, HUMAN-FACTOR VIII |
|
||||||||
|
|
(Hemofil®, Humafac®, Koate®, Factorate®, Profilate®) |
|
|||||||
|
|
Injection: Actual number of AHF shown on vial; 50 milliliters |
|
|||||||
|
|
|
|
|||||||
|
ANTIPYRINE AND BENZOCAINE (Auralgan®, Tympagesic®) |
|
||||||||
|
|
Otic Drops: 13 milliliters dropper bottle |
|
|||||||
|
|
|
|
|||||||
|
ANTIVENIN, BLACK WIDOW SPIDER BITE, EQUINE ORIGIN |
|
||||||||
|
|
Injection: 2.5 milliliters vial |
|
|||||||
|
|
|
|
|||||||
|
ANTIVENIN, SNAKE BITE, POLYVALENT (Crotaline Antivenin®) |
|
||||||||
|
|
Injection: 10 milliliters vial |
|
|||||||
|
|
|
|
|||||||
|
APRACLONIDINE HYDROCHLORIDE (Iopine®) |
|
||||||||
|
|
Ophthalmic Solution: 1%; 0.25 milliliter |
|
|||||||
|
|
Recommended dosage: one drop instilled into the operative eye one hour before surgery, and a second drop immediately following the procedure. |
|
|||||||
|
|
|
|
|||||||
|
AQUAPHOR (inpatient only) |
|
||||||||
|
|
Ointment: 16 oz |
|
|||||||
|
|
|
|
|||||||
|
ASCORBIC ACID (Vitamin C) |
|
||||||||
|
|
Tablet: 250 milligrams, 500 milligrams |
|
|||||||
|
|
Solution: 100 milligrams/ milliliter; 50 milliliters dropper bottle (Cecon®) |
|
|||||||
|
|
Injection: 500 milligrams/ milliliter; 1 milliliter |
|
|||||||
|
|
|
|
|||||||
|
ASPIRIN (Acetylsalicylic Acid) |
|
||||||||
|
|
Tablet: 80 milligrams, 325 milligrams |
|
|||||||
|
|
Tablet, enteric-coated: 325 milligrams |
|
|||||||
|
|
Suppository: 125 milligrams, 300 milligrams, 600 milligrams |
|
|||||||
|
|
|
||||||||
|
ASPIRIN/ EXTENDED-RELEASE DIPYRIDAMOLE, (Aggrenox®) |
|
||||||||
|
|
Capsule: 25 milligrams/ 200 milligrams |
|
|||||||
|
|
|
||||||||
|
ATENOLOL (Tenormin®) |
|
||||||||
|
|
Tablet: 25 milligrams, 50 milligrams |
|
|||||||
|
|
Injection: 0.5 milligrams/ milliliter; 10 milliliters |
|
|||||||
|
|
|
||||||||
|
ATOVAQUONE (Mepron®) |
|
||||||||
|
|
Suspension: 750 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
ATRACURIUM (Tracurium®) |
|
||||||||
|
|
Injection: 10 milligrams/ milliliter; 10 milliliters |
|
|||||||
|
|
Restricted to Anesthesiology |
|
|||||||
|
|
|
|
|||||||
|
ATROPINE SULFATE |
|
||||||||
|
|
Tablet: 0.4 milligrams |
|
|||||||
|
|
Injection: 0.4 milligrams/ milliliter; 20 milliliters (inhalation is non-formulary) |
|
|||||||
|
|
Injection: 0.1 milligrams/ milliliter; 10 milliliters Syringe |
|
|||||||
|
|
Injection: 0.3 milligrams/ milliliter; 1 milliliters |
|
|||||||
|
|
Injection: 0.4 milligrams/ milliliter; 1 milliliters, 0.5 milligram/ milliliter; 1 milliliter |
|
|||||||
|
|
Injection: 0.4 milligram/ milliliter; 20 milliliters vial |
|
|||||||
|
|
Injection: 1 milligram/ milliliter; 1 milliliters |
|
|||||||
|
|
Solution, ophthalmic: 1%; 1 milliliter, 5 milliliters, 15 milliliters |
|
|||||||
|
|
Ointment, ophthalmic: 1%, 3.5 gram tube |
|
|||||||
|
|
|
|
|||||||
|
AURANOFIN (Ridaura®) |
|
||||||||
|
|
Capsule: 3 milligrams |
|
|||||||
|
|
|
|
|||||||
|
AZATHIOPRINE |
|
||||||||
|
|
Tablet: 50 milligrams |
|
|||||||
|
|
Injection: 100 milligrams; 20 milliliters |
|
|||||||
|
|
|
|
|||||||
|
AZITHROMYCIN (ZITHROMAX®) |
|
||||||||
|
|
Tablet: 250 milligrams, 600 milligrams |
|
|||||||
|
|
Oral powder: 1 gram |
|
|||||||
|
|
Injection: 500 milligram vial |
|
|||||||
|
|
Injection: Premixed, 500 milligrams in 250 milliliters Dextrose 5% |
|
|||||||
|
|
|
|
|||||||
|
BACITRACIN |
|
||||||||
|
|
Injection: 50,000 units |
|
|||||||
|
|
Ophthalmic Ointment: 1/8oz |
|
|||||||
|
|
Ointment: |
|
|||||||
|
|
|
|
|||||||
|
BACLOFEN (Lioresal®) |
|
||||||||
|
|
Tablet: 10 milligrams |
|
|||||||
|
|
|
|
|||||||
|
BARIUM SULFATE |
|
||||||||
|
|
Suspension: 1% w/v |
|
|||||||
|
|
|
|
|||||||
|
C-BEER |
|
||||||||
|
|
12 ounce cans |
|
|||||||
|
|
|
|
|||||||
|
BENZALKONIUM CHLORIDE (Zephiran®) (inpatient only) |
|
||||||||
|
|
Solution: 17% |
|
|||||||
|
|
|
|
|||||||
|
BENZOCAINE (inpatient) |
|
||||||||
|
|
Ointment: 20%; 30 gram tube |
|
|||||||
|
|
Lubricant, intratracheal: 20%; 30 gram tube |
|
|||||||
|
|
Spray: 2oz (topical: Dermoplast®, Americaine®) |
|
|||||||
|
|
|
|
|||||||
|
BENZOYL PEROXIDE |
|
||||||||
|
|
Ointment: 10%; 1.5 oz |
|
|||||||
|
|
|
|
|||||||
|
BENZOYL PEROXIDE WITH SULFUR (Sulfoxyl®) (inpatient only) |
|
||||||||
|
|
Lotion: 10% Benzoyl Peroxide with 5% Sulfur; 2 oz |
|
|||||||
|
|
|
|
|||||||
|
BENZQUINAMIDE HYDROCHLORIDE (Emete-con®) |
|
||||||||
|
|
Injection: 25 milligrams/ milliliter; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
BENZTROPINE MESYLATE (Cogentin®) |
|
||||||||
|
|
Tablet: 0.5 milligrams, 1 milligrams, 2 milligrams |
|
|||||||
|
|
Injection: 1 milligrams/ milliliter; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
BENZYLPENICILLOYL POLYLYSINE (PrePen®) |
|
||||||||
|
|
Injection: single dose |
|
|||||||
|
|
|
|
|||||||
|
BEPRIDIL (Vascor®) |
|
||||||||
|
|
Tablet: 200 milligrams, 300 milligrams, 400 milligrams |
|
|||||||
|
|
Restricted to Cardiology |
|
|||||||
|
|
|
|
|||||||
|
BERACTANT (Survanta®) |
|
||||||||
|
|
Injection: 8 milliliters |
|
|||||||
|
|
|
|
|||||||
|
BETAMETHASONE |
|
||||||||
|
|
Cream: 0.05%; 15Gram tube as Dipropionate (Diprosone®) |
|
|||||||
|
|
Ointment: 0.05%; 15Gram tube as Dipropionate (Diprosone®) |
|
|||||||
|
|
Injection: 6 milligrams/ milliliter; 5 milliliters vial (Celestone Soluspan®) |
|
|||||||
|
|
|
|
|||||||
|
BETAXOLOL HYRODCHLORIDE (Betoptic®) |
|
||||||||
|
|
Ophthalmic solution: 0.5%; 10 milliliters |
|
|||||||
|
|
|
|
|||||||
|
BETHANECHOL CHLORIDE |
|
||||||||
|
|
Tablet: 10 milligrams, 25 milligrams |
|
|||||||
|
|
Injection, subcutaneous: 5 milligrams/ milliliters; 1 milliliter |
|
|||||||
|
|
|
|
|||||||
|
Biaxin®: see CLARITHROMYCIN |
|
||||||||
|
|
|
||||||||
|
BISACODYL |
|
||||||||
|
|
Tablet: 5 milligrams |
|
|||||||
|
|
Suppository: 10 milligrams |
|
|||||||
|
|
|
|
|||||||
|
BISMUTH SUBSALICYLATE (PeptoBismol®) |
|
||||||||
|
|
Tablet: 262 milligrams (inpatient only) |
|
|||||||
|
|
Suspension: 262 milligrams/5 milliliters; 240 milliliters bottle |
|
|||||||
|
|
|
|
|||||||
|
BLEOMYCIN SULFATE (Blenoxane®) |
|
||||||||
|
|
Injection: 15 units/ampule (1 unit equals 1 milligrams) |
|
|||||||
|
|
|
|
|||||||
|
C-BOURBON/WHISKEY |
|
||||||||
|
|
|
|
|||||||
|
BRETYLIUM TOSYLATE (Bretyol®) |
|
||||||||
|
|
Injection: 50 milligrams/ milliliter; 10 milliliters |
|
|||||||
|
|
|
|
|||||||
|
BRIMONIDINE (Alphagan P®) |
|
||||||||
|
|
Solution, ophthalmic: 0.15% 10 milliliters, 15 milliliters |
|
|||||||
|
|
|
|
|||||||
|
BROMOCRIPTINE (Parlodel®) |
|
||||||||
|
|
Tablet: 2.5 milligrams |
|
|||||||
|
|
|
|
|||||||
|
BUMETANIDE (Bumex®) |
|
||||||||
|
|
Injection Only: 0.5 milligrams/2 milliliters; 2 milliliters |
|
|||||||
|
|
Restricted to inpatient, injection only. |
|
|||||||
|
|
|
|
|||||||
|
BUPIVACAINE HYDROCHLORIDE (Marcaine®, Sensorcaine®) |
|
||||||||
|
|
Injection: 0.25%; SDV |
|
|||||||
|
|
Injection: 0.5%; SDV |
|
|||||||
|
|
Injection: 0.75%; SDV |
|
|||||||
|
|
|
||||||||
|
BUPIVACAINE WITH DEXTROSE (Marcaine®) |
|
||||||||
|
|
Injection: 7.5 milligrams with 82.5 milligrams Dextrose; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
BUSULFAN (Myleran®) (inpatient only) |
|
||||||||
|
|
Tablet: 2 milligrams |
|
|||||||
|
|
|
|
|||||||
|
BUTORPHANOL (Stadol®) |
|
||||||||
|
|
Injection; 1 milligrams/ milliliter; 1 milliliter |
|
|||||||
|
|
Injection: 2 milligrams/ milliliter; 1 milliliter, 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CAFFEINE AND SODIUM BENZOATE |
|
||||||||
|
|
Injection: 250 milligrams/ milliliter; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CALAMINE LOTION (inpatient only) |
|
||||||||
|
|
Lotion, topical; 120 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CALCIFEDIOL (Calderol®) |
|
||||||||
|
|
Capsule: 20 micrograms, 50 micrograms |
|
|||||||
|
|
|
|
|||||||
|
CALCITONIN SALMON (Calcimar®) |
|
||||||||
|
|
Injection: 200 international units/ milliliter; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CALCITRIOL (Rocaltrol®) |
|
||||||||
|
|
Capsule: 0.25 micrograms |
|
|||||||
|
|
|
|
|||||||
|
CALCIUM ACETATE (PhosLo®) |
|
||||||||
|
|
Tablet: 667 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CALCIUM CARBONATE |
|
||||||||
|
|
Tablet: 250 milligrams, 500 milligrams |
|
|||||||
|
|
|
||||||||
|
CALCIUM CHLORIDE |
|
||||||||
|
|
Injection: 10%, 1 gram; 10 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CALCIUM DISODIUM EDETATE (Calcium Disodium Versenate®, EDTA Calcium) |
|
||||||||
|
|
Injection: 200 milligrams/ milliliter; 5 milliliters ampule |
|
|||||||
|
|
|
|
|||||||
|
CALCIUM GLUBIONATE (Neo-Calglucon®) |
|
||||||||
|
|
Liquid: 1.8 grams/5 milliliters; 16 ounces |
|
|||||||
|
|
|
||||||||
|
CALCIUM GLUCONATE |
|
||||||||
|
|
Injection: 10%; 10 milliliters, 100 milliliters, 200 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CAMPHOR/MENTHOL (Sarna®) |
|
||||||||
|
|
Lotion: 222 milliliters (7.5oz bottle) |
|
|||||||
|
|
|
|
|||||||
|
CAPTOPRIL (Capoten®) |
|
||||||||
|
|
Tablet: 12.5 milligrams, 25 milligrams, 50 milligrams, 100 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CARBAMIDE PEROXIDE (Gly-Oxide®) (inpatient only) |
|
||||||||
|
|
Liquid: 10%; 15 milliliters bottle |
|
|||||||
|
|
|
|
|||||||
|
CARBAMAZEPINE |
|
||||||||
|
|
Tablet, Chew: 100 milligrams |
|
|||||||
|
|
Tablet: 200 milligrams |
|
|||||||
|
|
Liquid: 100 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CARBOPROST TROMETHAMINE (Prostin 15M®) |
|
||||||||
|
|
Injection: 250micrograms/ milliliter, 1 milliliters amp |
|
|||||||
|
|
|
|
|||||||
|
CARMUSTINE (BCNU, BiCNU®) |
|
||||||||
|
|
Injection: 100 milligram vial |
|
|||||||
|
|
|
|
|||||||
|
CARVEDILOL (Coreg®) |
|
||||||||
|
|
Tablet: 6.25 milligrams, 12.5 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CASTOR OIL (inpatient only) |
|
||||||||
|
|
Liquid: 30 milliliters unit dose |
|
|||||||
|
|
|
|
|||||||
|
CEFAZOLIN SODIUM (Ancef®) |
|
||||||||
|
|
Injection: 1 gram, 10 gram vials |
|
|||||||
|
|
Injection: Premixed, 1 gram in Dextrose 5% (D5W) 50 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CEFEPIME (Maxipime®) |
|
||||||||
|
|
Indications for use of cefepime at The MED are: |
|
|||||||
|
|
· Infections with C&S documented gram negative organisms which are resistant to more narrow spectrum agents |
|
|||||||
|
|
· Empiric use may include: a. Suspected or proven gram negative bacillary meningitis b. Nosocomial pneumonia or sepsis |
|
|||||||
|
|
· No third or fourth generation cephalosporin is approved for surgical prophylaxis at The MED. |
|
|||||||
|
|
The usual adult daily dosage range for cefepime is 1-2 grams IV every 12 hours; Dosage must be decreased in renal insufficiency: |
|
|||||||
|
|
CrCl
(mls/minute) 30-60 11-29 <10 |
Mild to Mod.
Infection 500 milligrams every24h 500 milligrams every24h 250 milligrams every24h |
Severe Infection 2 grams every 24 hours 1 gram every 24 hours 500 milligrams every 24 hours |
|
|||||
|
|
|
|
|||||||
|
CEFOTETAN (Cefotan®) |
|
||||||||
|
|
Injection: 2 grams and 10 grams vials |
|
|||||||
|
|
Injection: Premixed, 2 gram |
|
|||||||
|
|
|
|
|||||||
|
CEFTRIAXONE (Rocephin®) |
|
||||||||
|
|
Indications for use of ceftriaxone at The MED are: |
|
|||||||
|
|
· Infections with C & S documented gram negative organisms which are resistant to more narrow spectrum agents |
|
|||||||
|
|
· Empiric use may include: a. Suspected or proven gram negative bacillary meningitis b. Nosocomial pneumonia or sepsis or community acquired pneumonia c. Underlying disease state which predisposes to gram-negative infections |
|
|||||||
|
|
· No third generation is approved for surgical prophylaxis at The MED. |
|
|||||||
|
|
· Usual adult daily dosage range for ceftriaxone is 1-2 grams given every 24 hours; doses of up to 4grams/day may be indicated for meningitis |
|
|||||||
|
|
· Every 12 hour dosing with ceftriaxone usually only used for meningitis |
|
|||||||
|
|
· No dosage adjustment is required in renal insufficiency |
|
|||||||
|
|
Injection: 1 gram premixed in 50 milliliters D5W |
|
|||||||
|
|
Injection: 2 gram premixed in 50 milliliters D5W |
|
|||||||
|
|
|
|
|||||||
|
Celexa®: see CITALOPRAM |
|
||||||||
|
|
|
|
|||||||
|
CEPHALEXIN |
|
||||||||
|
|
Capsule: 250 milligrams, 500 milligrams |
|
|||||||
|
|
Oral Suspension: 250 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CHARCOAL, ACTIVATED |
|
||||||||
|
|
Suspension: 25grams/120 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CHERRY SYRUP |
|
||||||||
|
|
Liquid: 480 milliliters bottle |
|
|||||||
|
|
|
|
|||||||
|
C-CHLORAL HYDRATE |
|
||||||||
|
|
Capsule: 500 milligrams |
|
|||||||
|
|
Liquid: 500 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CHLORAMBUCIL (Leukeran®) |
|
||||||||
|
|
Tablet: 2 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CHLORAMINE, AROMATIC (Dakin's Solution) |
|
||||||||
|
|
Mouthwash: Bulk |
|
|||||||
|
|
|
|
|||||||
|
C-CHLORDIAZEPOXIDE (Librium®) |
|
||||||||
|
|
Capsule: 5 milligrams, 10 milligrams, 25 milligrams |
|
|||||||
|
|
Injection: 100 milligrams ampule |
|
|||||||
|
|
|
|
|||||||
|
CHLORHEXIDINE GLUCONATE (Peridex ®) |
|
||||||||
|
|
Solution: 0.12 %, 473 milliliters bottle |
|
|||||||
|
|
|
|
|||||||
|
CHLOROQUIN PHOSPHATE (Aralen®) |
|
||||||||
|
|
Tablet: 250 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CHLOROPROCAINE HYDROCHLORIDE (Nesacaine®) |
|
||||||||
|
|
Injection: 2%, 3%; single dose vial |
|
|||||||
|
|
For Use in Caudal and Epidural Anesthesia |
|
|||||||
|
|
|
|
|||||||
|
CHLORPHENIRAMINE MALEATE |
|
||||||||
|
|
Tablet: 4 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CHLORPROMAZINE HYDROCHLORIDE |
|
||||||||
|
|
Tablet: 10 milligrams, 25 milligrams, 50 milligrams, 100 milligrams |
|
|||||||
|
|
Injection: 25 milligrams/ milliliter; 2 milliliters |
|
|||||||
|
|
Syrup: 10 milligrams/5 milliliters; 120 milliliters bottle |
|
|||||||
|
|
Liquid, Concentrate: 30 milligrams/ milliliter; 120 milliliters bottle |
|
|||||||
|
|
Liquid, Concentrate: 100 milligrams/ milliliter; 120 milliliters bottle |
|
|||||||
|
|
Suppository: 25 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CHLORPROPAMIDE |
|
||||||||
|
|
Tablet: 100 milligrams, 250 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CHOLESTYRAMINE (Questran-Lite®) |
|
||||||||
|
|
Powder: 9 gram packet containing 4gram anhydrous cholestyramine |
|
|||||||
|
|
|
|
|||||||
|
CHOLINE SALICYLATE (Arthropan®) (inpatient only) |
|
||||||||
|
|
Liquid: 870 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CHORIONIC GONADOTROPIN (Antuitrin-S®, A.P.L.®) |
|
||||||||
|
|
Injection: 5000 units; 10 milliliters vial |
|
|||||||
|
|
|
|
|||||||
|
CHROMIUM CHLORIDE (Chromium Trace Metal) |
|
||||||||
|
|
Injection: 4 micrograms/ milliliter; 10 milliliters vial |
|
|||||||
|
|
|
|
|||||||
|
CHYMOTRYPSIN (Alpha Chymotrypsin) |
|
||||||||
|
|
Injection: 750 units powder for solution with 10 milliliters diluent |
|
|||||||
|
|
|
||||||||
|
CIMETIDINE (Tagamet®) |
|
||||||||
|
|
Tablet: 200 milligrams, 300 milligrams, 400 milligrams |
|
|||||||
|
|
Injection: 300 milligrams/2 milliliters; 2 milliliters, 8 milliliters vial, premix 50 milliliters |
|
|||||||
|
|
Elixir: 300 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CIPROFLOXACIN (Ciloxan®) |
|
||||||||
|
|
Ophthalmic solution (Ciloxan®): 0.3% 5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CIPROFLOXACIN (Cipro®) |
|
||||||||
|
|
Tablet: 250 milligrams, 500 milligrams |
|
|||||||
|
|
Injection: 200 milligrams/20 milliliters |
|
|||||||
|
|
Intravenous Injection: Premixed, 400 milligrams in 200 milliliters D5W |
|
|||||||
|
|
|
|
|||||||
|
CITALOPRAM (Celexa®) |
|
||||||||
|
|
Tablet: 10 milligrams, 20 milligrams, 40 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CISATRACURIUM (Nimbex®) |
|
||||||||
|
|
Injection: 2 milligrams/ milliliter; 5 milliliters, 10 milliliters |
|
|||||||
|
|
10 milligrams/milliliter; 20 milliliters (ICU only) |
|
|||||||
|
|
|
|
|||||||
|
CISPLATIN (Platinol®) |
|
||||||||
|
|
Injection: 1 milligram/ milliliter; 50 milligram vial |
|
|||||||
|
|
|
|
|||||||
|
CITRIC ACID AND SODIUM CITRATE (Bicitra®) |
|
||||||||
|
|
Solution: Citric acid 334 milligrams and Sodium Citrate |
|
|||||||
|
|
500 milligrams/5 milliliters; 15 milliliters unit dose |
|
|||||||
|
|
|
|
|||||||
|
Citrovorum Factor: see LEUCOVORIN, CALCIUM |
|
||||||||
|
|
|
||||||||
|
CLARITHROMYCIN (Biaxin®) |
|
||||||||
|
|
Tablet: 500 milligrams |
|
|||||||
|
|
Initiation restricted to ID and Adult Special Care for treatment/prophylaxis of MAI |
|
|||||||
|
|
|
|
|||||||
|
Clearasil®: See TRICLOSAN |
|
||||||||
|
|
|
|
|||||||
|
CLINDAMYCIN HYDROCHLORIDE |
|
||||||||
|
|
Capsule: 150 milligrams |
|
|||||||
|
|
Powder for oral suspension: 75 milligrams/5 milliliters; 100 milliliters bottle |
|
|||||||
|
|
|
|
|||||||
|
CLINDAMYCIN PHOSPHATE |
|
||||||||
|
|
Injection: 150 milligrams/ milliliter; 2 milliliters, 4 milliliters, 6 milliliters, 60 milliliters vial |
|
|||||||
|
|
Premix: 600 milligrams, 900 milligrams in D5W 50 milliliters |
|
|||||||
|
|
Vaginal Cream: 2% |
|
|||||||
|
|
|
|
|||||||
|
CLOFAZIMINE (Lamprene®) |
|
||||||||
|
|
Capsule: 100 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CLOMIPHENE CITRATE (Clomid®) (inpatient only) |
|
||||||||
|
|
Tablet: 50 milligrams |
|
|||||||
|
|
|
|
|||||||
|
C-CLONAZEPAM (Klonopin®) |
|
||||||||
|
|
Tablet: 1 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CLONIDINE HYDROCHLORIDE |
|
||||||||
|
|
Tablet: 0.1 milligrams, 0.2 milligrams, 0.3 milligrams |
|
|||||||
|
|
|
||||||||
|
CLOPIDOGREL (Plavix®) |
|
||||||||
|
|
Tablet: 75 milligrams |
|
|||||||
|
|
|
|
|||||||
|
C-CLORAZEPATE DIPOTASSIUM (Tranxene®) |
|
||||||||
|
|
Tablet: 3.75 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CLOTRIMAZOLE |
|
||||||||
|
|
Oral lozenges only (Mycelex®) |
|
|||||||
|
|
Troche: 10 milligram |
|
|||||||
|
|
Topical Solution (Restricted to Plastics) |
|
|||||||
|
|
|
|
|||||||
|
COAL TAR |
|
||||||||
|
|
Bath Oil: 2.5% (Balnetar®) |
|
|||||||
|
|
|
||||||||
|
COAL TAR, SULFUR, SALICYLIC ACID |
|
||||||||
|
|
Shampoo: 4oz (Sebutone®) contains Coal tar 0.5% |
|
|||||||
|
|
Salicylic Acid 2% |
|
|||||||
|
|
|
|
|||||||
|
C II-COCAINE HYDROCHLORIDE |
|
||||||||
|
|
Solution, topical: 4%; 4 milliliters |
|
|||||||
|
|
|
|
|||||||
|
COCOA BUTTER |
|
||||||||
|
|
Topical: 1 oz. |
|
|||||||
|
|
|
|
|||||||
|
C II-CODEINE PHOSPHATE |
|
||||||||
|
|
Injection: 30 milligrams, 60 milligrams; 1 milliliter syringes |
|
|||||||
|
|
|
|
|||||||
|
C II-CODEINE SULFATE |
|
||||||||
|
|
Tablet (oral): 15 milligrams, 30 milligrams |
|
|||||||
|
|
|
|
|||||||
|
COD LIVER OIL (inpatient only) |
|
||||||||
|
|
Bulk: 120 milliliters bottle |
|
|||||||
|
|
|
|
|||||||
|
COLCHICINE |
|
||||||||
|
|
Tablet: 0.6 milligrams |
|
|||||||
|
|
Injection: 1 milligram; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
COLESTIPOL (Colestid®) (inpatient only) |
|
||||||||
|
|
Granules: 5 gram packets |
|
|||||||
|
|
|
|
|||||||
|
COLISTIN SULFATE (Coly-Mycin S®) (inpatient only) |
|
||||||||
|
|
Oral Suspension: 60 milliliters |
|
|||||||
|
|
|
|
|||||||
|
COLLAGENASE (Santyl®) (outpatient only) |
|
||||||||
|
|
Ointment: 15 gram |
|
|||||||
|
|
|
|
|||||||
|
COLLODION, FLEXIBLE |
|
||||||||
|
|
Bulk, solution |
|
|||||||
|
|
|
|
|||||||
|
COPPER (Trace Metal) |
|
||||||||
|
|
Injection: 4 milligrams/ milliliter; 10 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CORTICOTROPIN (ACTH, Acthar®) (cosynntropin) |
|
||||||||
|
|
Injection: 25 units/vial |
|
|||||||
|
|
Injection: 40 units/vial |
|
|||||||
|
|
|
|
|||||||
|
CORTICOTROPIN, REPOSITORY (H.P. Acthar Gel®) |
|
||||||||
|
|
Injection: 40 units/ milliliter |
|
|||||||
|
|
|
|
|||||||
|
Cosopt®: see DORZOLAMIDE AND TIMOLOL |
|
||||||||
|
|
|
|
|||||||
|
Coumadin®: see WARFARIN SODIUM |
|
||||||||
|
|
|
|
|||||||
|
CROMOLYN SODIUM (Aarane®, Intal®) |
|
||||||||
|
|
Capsule: 20 milligrams for inhalation |
|
|||||||
|
|
Spinhaler: for use with above Capsule |
|
|||||||
|
|
Inhaler: 112 Spray |
|
|||||||
|
|
Solution, nebulizer: 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CYANIDE ANTIDOTE PAK |
|
||||||||
|
|
Each pak contains: Sodium Nitrite Injection 300 milligrams/10 milliliters, |
|
|||||||
|
|
Sodium Thiosulfate Injection 12.5grams/50 milliliters, Amyl Nitrite Inhalant 0.3 milliliter |
|
|||||||
|
|
|
|
|||||||
|
CYANOCOBALAMIN (Vitamin B12) |
|
||||||||
|
|
Injection: 1000 micrograms; 1 milliliter |
|
|||||||
|
|
|
|
|||||||
|
CYCLOBENZAPRINE (Flexeril®) |
|
||||||||
|
|
Tablet: 10 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CYCLOPENTOLATE HYDROCHLORIDE (Cyclogyl®) |
|
||||||||
|
|
Solution, ophthalmic: 1/2%; 5 milliliters dropper bottle |
|
|||||||
|
|
Solution, ophthalmic: 1%; 5 milliliters dropper bottle |
|
|||||||
|
|
Solution, ophthalmic: 2%; 5 milliliters dropper bottle |
|
|||||||
|
|
|
||||||||
|
CYCLOPENTOLATE/PHENYLEPHRINE (Cyclomydril®) |
|
||||||||
|
|
Solution, ophthalmic: 0.2%, 1%; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CYCLOPHOSPHAMIDE (Cytoxan®) |
|
||||||||
|
|
Tablet: 25 milligrams, 50 milligrams |
|
|||||||
|
|
Injection: 100 milligrams, 200 milligrams, 500 milligram vials |
|
|||||||
|
|
|
|
|||||||
|
CYCLOSERINE |
|
||||||||
|
|
Capsule: 250 milligrams |
|
|||||||
|
|
|
|
|||||||
|
CYPROHEPTADINE HYDROCHLORIDE (Periactin®) |
|
||||||||
|
|
Tablet: 4 milligrams |
|
|||||||
|
|
Syrup: 2 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
CYTARABINE (Cytosar®) |
|
||||||||
|
|
Injection: 100 milligrams, 500 milligrams, 1gram |
|
|||||||
|
|
|
|
|||||||
|
DACARBAZINE CITRATE (DTIC®, DIC) |
|
||||||||
|
|
Injection: 100 milligrams, 200 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DACTINOMYCIN (Actinomycin-D, Cosmegen®) |
|
||||||||
|
|
Injection: 0.5 milligram vial |
|
|||||||
|
|
|
|
|||||||
|
DANAZOL (Danocrine®) |
|
||||||||
|
|
Capsule: 200 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DANTROLENE SODIUM (Dantrium®) |
|
||||||||
|
|
Capsule: 25 milligrams, 50 milligrams |
|
|||||||
|
|
Injection: 20 milligrams/ milliliter; 70 milliliters vial |
|
|||||||
|
|
|
|
|||||||
|
DAPSONE (Avlosulfon®) |
|
||||||||
|
|
Tablet: 25 milligrams, 100 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DAUNORUBICIN (Cerubidine®) |
|
||||||||
|
|
Injection: 5 milligrams/ milliliter; 4 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DDAVP®: see DESMOPRESSIN ACETATE |
|
||||||||
|
|
|
|
|||||||
|
DEFEROXAMINE MESYLATE (Desferal®) |
|
||||||||
|
|
Injection: 500 milligrams; 5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DESFLURANE (Suprane®) |
|
||||||||
|
|
Liquid for inhalation: 240 milliliters vial |
|
|||||||
|
|
(Restricted to Anesthesiology) |
|
|||||||
|
|
|
|
|||||||
|
DESIPRAMINE HCL (such as Norpramin®) |
|
||||||||
|
|
Tablet: 10 milligrams, 25 milligrams, 50 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DESMOPRESSIN ACETATE (DDAVP®) |
|
||||||||
|
|
Injection: 4 micrograms/ milliliter |
|
|||||||
|
|
Intranasal: 0.01%; 2.5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DEXAMETHASONE (such as Decadron®) |
|
||||||||
|
|
Tablet: 0.5 milligrams, 0.75 milligrams, 2 milligrams, 4 milligrams |
|
|||||||
|
|
Elixir: 0.5 milligrams/5 milliliters, 1 milligram/ milliliter |
|
|||||||
|
|
|
|
|||||||
|
DEXAMETHASONE AND TOBRAMYCIN (TobraDex®) |
|
||||||||
|
|
Ointment, ophthalmic: 3.5 gram tube |
|
|||||||
|
|
Suspension, ophthalmic: 2.5 milliliters, 5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DEXAMETHASONE, NEOMYCIN AND POLYMYXIN B SULFATE (Maxitrol®) |
|
||||||||
|
|
Suspension, ophthalmic: Dexamethasone 0.1%, Neomycin 3.5 milligrams, Polymyxin |
|
|||||||
|
|
B Sulfate 6000 units/ milliliter; 5 milliliters dropper bottle |
|
|||||||
|
|
Ointment, ophthalmic: Dexamethasone 0.1%, Neomycin 3.5grams, Polymyxin B |
|
|||||||
|
|
Sulfate 10,000u/grams; 3.5gram tube |
|
|||||||
|
|
|
|
|||||||
|
DEXAMETHASONE SODIUM PHOSPHATE |
|
||||||||
|
|
Injection: 4 milligrams/ milliliter; 1 milliliter, 5 milliliters vial |
|
|||||||
|
|
Suspension, ophthalmic: 0.1%; 5 milliliters dropper bottle |
|
|||||||
|
|
Ointment, ophthalmic: 0.05%; 3.5 gram tube |
|
|||||||
|
|
|
|
|||||||
|
DEXTRAN (Hyskon®) |
|
||||||||
|
|
Injection: Dextran 70/100 milliliters bottle |
|
|||||||
|
|
|
|
|||||||
|
DEXTROSE |
|
||||||||
|
|
Injection: 10%; 5 milliliters |
|
|||||||
|
|
Injection: 50%; 50 milliliters syringe and vial |
|
|||||||
|
|
Oral Liquid: 100Grams/240 milliliters bottle (for Glucose Tolerance Test) |
|
|||||||
|
|
|
|
|||||||
|
C-DIAZEPAM (Valium®) |
|
||||||||
|
|
Injection: 5 milligrams/ milliliter; 2 milliliters |
|
|||||||
|
|
Tablet: 2 milligrams, 5 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DIATRIZOATE MEGLUMINE (Hypaque®) |
|
||||||||
|
|
Injection 30%: 100 milliliters, 300 milliliters |
|
|||||||
|
|
Injection 50%: 50 milliliters |
|
|||||||
|
|
Injection 60%: 50 milliliters, 100 milliliters, 150 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM (Hypaque-76®) |
|
||||||||
|
|
Injection: 50 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DIATRIZOATE SODIUM (Hypaque®) |
|
||||||||
|
|
Injection 25%: 300 milliliters |
|
|||||||
|
|
Oral Solution: 120 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DIAZOXIDE (Hyperstat®) |
|
||||||||
|
|
Injection: 15 milligrams/ milliliter; 20 milliliters ampule |
|
|||||||
|
|
|
|
|||||||
|
DIBUCAINE (Nupercainal®) (inpatient only) |
|
||||||||
|
|
Ointment: 1%; 30 gram tube |
|
|||||||
|
|
Suppositories |
|
|||||||
|
|
|
|
|||||||
|
DICLOXACILLIN SODIUM (Dynapen®) |
|
||||||||
|
|
Capsule: 125 milligrams, 250 milligrams |
|
|||||||
|
|
Powder for oral suspension: 62.5 milligrams/5 milliliters; 80 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DIDANOSINE (DDI) (Videx®) |
|
||||||||
|
|
Tablet: 25 milligrams, 100 milligrams |
|
|||||||
|
|
Initiation restricted to ID and Adult Special Care |
|
|||||||
|
|
|
|
|||||||
|
Dideoxytidine (DDC), Hivid®: see ZALCITABINE |
|
||||||||
|
|
|
|
|||||||
|
DICHLODIFLUOROMETHANE (Fluori-Methane®) |
|
||||||||
|
|
Liquid: 4 oz (120 milliliters) bottle |
|
|||||||
|
|
|
|
|||||||
|
Digibind®: see DIGOXIN IMMUNE FAB |
|
||||||||
|
|
|
|
|||||||
|
DIGOXIN (Lanoxin®) |
|
||||||||
|
|
Elixir, pediatric: 0.05 milligrams/ milliliter; 60 milliliters dropper bottle |
|
|||||||
|
|
Injection: 0.1 milligrams/ milliliter; 1 milliliter ampule (pediatric) |
|
|||||||
|
|
Injection: 0.25 milligrams/ milliliter; 1 milliliter, 2 milliliters |
|
|||||||
|
|
Tablet: 0.125 milligrams, 0.25 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DIGOXIN IM MUNE FAB (Digibind®) |
|
||||||||
|
|
Injection: 40 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DIHYDROERGOTAMINE (DHE-45®) |
|
||||||||
|
|
Injection: 1 milligrams; 1 milliliters ampule |
|
|||||||
|
|
|
|
|||||||
|
DIHYDROTACHYSTEROL (Hytakerol®) |
|
||||||||
|
|
Tablet: 0.125 milligrams |
|
|||||||
|
|
Liquid: 0.2 milligrams/ milliliters; 30 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DILTIAZEM (Cardizem®, Cardizem CD) |
|
||||||||
|
|
Tablet: 30 milligrams, 60 milligrams |
|
|||||||
|
|
Sustained release: 120 milligrams CD, 180 milligrams CD, 240 milligrams CD, 300 milligrams CD |
|
|||||||
|
|
Injection: 5 milligrams/ milliliter; 5 milliliters vial |
|
|||||||
|
|
|
|
|||||||
|
DIMERCAPROL (BAL®, British Anti-Lewiste®) |
|
||||||||
|
|
Injection: 10% (100 milligrams/ milliliter) in peanut oil; 3 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DIOCTYL SODIUM SULFOSUCCINATE (Docusate Sodium, Colace®) |
|
||||||||
|
|
Soft gelatin capsule: 100 milligrams |
|
|||||||
|
|
Solution: 100 milligrams/30 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DIPHENHYDRAMINE AND AMMONIUM CHLORIDE |
|
||||||||
|
|
Liquid: diphenhydramine 12.5 milligrams, Ammonium Chloride 125 milligrams, Sodium |
|
|||||||
|
|
Citrate 50 milligrams, Chloroform 20 milligrams, Menthol 1 milligrams, and Alcohol 5%/30 milliliters; 5 milliliters, 10 milliliters, and 120 milliliters |
|
|||||||
|
|
|
||||||||
|
DIPHENHYDRAMINE HYDROCHLORIDE (Benadryl®) |
|
||||||||
|
|
Capsule: 25 milligrams, 50 milligrams |
|
|||||||
|
|
Elixir: 12.5 milligrams/5 milliliters |
|
|||||||
|
|
Injection: 50 milligrams/ milliliter; 1 milliliters |
|
|||||||
|
|
|
|
|||||||
|
C-DIPHENOXYLATE HCl WITH ATROPINE SULFATE (Lomotil®) |
|
||||||||
|
|
Liquid: Diphenoxylate 2.5 milligrams with Atropine |
|
|||||||
|
|
Sulfate 0.025 milligrams/5 milliliters; 60 milliliters bottle |
|
|||||||
|
|
Tablet: Diphenoxylate 2.5 milligrams with atropine 0.025 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DIPHTHERIA ANTITOXIN |
|
||||||||
|
|
Injection: 20,000u vial |
|
|||||||
|
|
|
|
|||||||
|
DIPHTHERIA AND TETANUS TOXOIDS, ADSORBED |
|
||||||||
|
|
Injection: 0.5 milliliter/dose |
|
|||||||
|
|
|
|
|||||||
|
DIPHTHERIA AND TETANUS TOXIDS WITH PERTUSSIS VACCINE COMBINED ADSORBED (Triple Antigen, DPT) |
|
||||||||
|
|
Injection: 5 milliliters vial |
|
|||||||
|
|
|
|
|||||||
|
DIPHTHERIA TOXIN, DIAGNOSTIC (Schick Test) |
|
||||||||
|
|
Injection: 10 tests/ milliliter; 1 milliliter vial |
|
|||||||
|
|
|
|
|||||||
|
DIPYRIDAMOLE (such as Persantine®) (inpatient only) |
|
||||||||
|
|
Tablet: 25 milligrams, 75 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DISODIUM EDETATE (Endrate®, Sodium Versenate®) |
|
||||||||
|
|
Injection: 200 milligrams/ milliliter; 5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DISOPYRAMIDE PHOSPHATE (Norpace®) |
|
||||||||
|
|
Capsule: 100 milligrams, 150 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DOBUTAMINE (Dobutrex®) |
|
||||||||
|
|
Injection: 250 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DORZOLAMIDE (Trusopt®) |
|
||||||||
|
|
Solution, ophthalmic: 2% |
|
|||||||
|
MOXIFLOXACIN (Vigamox®) |
|
||||||||
|
|
Solution, ophthalmic: 0.5%, 3 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DORZOLAMIDE AND TIMOLOL (Cosopt®) |
|
||||||||
|
|
Solution, ophthalmic: 5 milliliters, 10 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DOXAPRAM HYDROCHLORIDE (Dopram®) |
|
||||||||
|
|
Injection: 20 milligrams/ milliliter; 20 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DOXEPIN HYDROCHLORIDE |
|
||||||||
|
|
Capsule: 10 milligrams, 25 milligrams, 50 milligrams, 75 milligrams, 100 milligrams |
|
|||||||
|
|
|
|
|||||||
|
DOXEPIN HYDROCHLORIDE (Prudoxin®, Zonalon®) |
|
||||||||
|
|
Cream 5% |
|
|||||||
|
|
|
|
|||||||
|
DOXORUBICIN HYDROCHLORIDE (Adriamycin®) |
|
||||||||
|
|
Injection: 10 milligram vial, 50 milligram vial |
|
|||||||
|
|
|
|
|||||||
|
DOXYCYCLINE (Vibramycin®) |
|
||||||||
|
|
Capsule: 100 milligrams |
|
|||||||
|
|
Injection: 100 milligrams, 200 milligram vials |
|
|||||||
|
|
Syrup: 50 milligrams/5 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DROPERIDOL HYDROCHLORIDE (Inapsine®) |
|
||||||||
|
|
Injection: 2.5 milligrams/ milliliter; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
DROTRECOGIN ALFA (Xigris®) |
|
||||||||
|
|
Injection: 5 milligrams, 20 milligram vials |
|
|||||||
|
|
|
||||||||
|
Dyazide®: see TRIAMTERENE/HYDROCHLOROTHIAZIDE |
|
||||||||
|
|
|
|
|||||||
|
EDROPHONIUM CHLORIDE (Tensilon®) |
|
||||||||
|
|
Injection: 10 milligrams/ milliliter; 1 milliliters, 10 milliliters |
|
|||||||
|
|
|
|
|||||||
|
ENALAPRILAT (Vasotec®) |
|
||||||||
|
|
Injection Only: 1.25 milligrams/ milliliter; 2 milliliters |
|
|||||||
|
|
|
|
|||||||
|
ENFLURANE (Ethrane®) |
|
||||||||
|
|
Liquid for inhalation: 250 milliliters vial |
|
|||||||